# Corvex, Inc.: overview MOVE · Nasdaq · CIK 1734750 · [Technology](/sectors/technology.md) · fiscal year ends Dec 31 Pages: [Overview](/companies/move.md) · [Financials](/companies/move/financials.md) · [Filings](/companies/move/filings.md) · [Insiders](/companies/move/insiders.md) Latest reported revenue: [$3.8m](/filings/0001213900-26-090091.md) for Q2 FY2026, three months to 2026-06-30, from the 10-Q filed Aug 14, 2026 (XBRL us-gaap:Revenues, accession 0001213900-26-090091). ## Last eight quarters | Line item | Unit | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Revenue | $m | [0.1](/filings/0001213900-25-110877.md) | [0.1 d](/filings/0001213900-26-036609.md) | [0.2](/filings/0001213900-26-058993.md) | [0.1](/filings/0001213900-26-090091.md) | [0.1](/filings/0001213900-25-110877.md) | [0.0 d](/filings/0001213900-26-036609.md) | [0.5](/filings/0001213900-26-058993.md) | [3.8](/filings/0001213900-26-090091.md) | | Gross margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | | Operating margin | % | [(14758.0%)](/filings/0001213900-25-110877.md) | [(4227.0%) d](/filings/0001213900-26-036609.md) | [(2542.7%)](/filings/0001213900-26-058993.md) | [(3165.0%)](/filings/0001213900-26-090091.md) | [(3238.8%)](/filings/0001213900-25-110877.md) | [(10031.8%) d](/filings/0001213900-26-036609.md) | [(950.4%)](/filings/0001213900-26-058993.md) | [(400.3%)](/filings/0001213900-26-090091.md) | | Net margin | % | [(14402.0%)](/filings/0001213900-25-110877.md) | [(4158.6%) d](/filings/0001213900-26-036609.md) | [(2513.6%)](/filings/0001213900-26-058993.md) | [(3131.1%)](/filings/0001213900-26-090091.md) | [(5036.3%)](/filings/0001213900-25-110877.md) | [(13302.3%) d](/filings/0001213900-26-036609.md) | [(981.4%)](/filings/0001213900-26-058993.md) | [(335.8%)](/filings/0001213900-26-090091.md) | | Diluted EPS | $ per share | [(10.56)](/filings/0001213900-25-110877.md) | not reported | [(5.35)](/filings/0001213900-26-058993.md) | [(3.05)](/filings/0001213900-26-090091.md) | [(4.73)](/filings/0001213900-25-110877.md) | not reported | [(3.13)](/filings/0001213900-26-058993.md) | [(5.12)](/filings/0001213900-26-090091.md) | | Free cash flow | $m | [(5.7) d](/filings/0001213900-25-110877.md) | [(4.6) d](/filings/0001213900-26-036609.md) | not reported | not reported | not reported | not reported | [(10.5)](/filings/0001213900-26-058993.md) | [(5.5) d](/filings/0001213900-26-090091.md) | - Revenue. XBRL Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure. - Gross margin (gross profit / revenue). XBRL Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure. - Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure. - Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure. - Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted. - Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. Derived values: 9-month figure less the 6-month figure; 12-month figure less the 9-month figure; 6-month figure less the 3-month figure. ## Last five fiscal years | Line item | Unit | FY2021 (2021-12-31) | FY2022 (2022-12-31) | FY2023 (2023-12-31) | FY2024 (2024-12-31) | FY2025 (2025-12-31) | | --- | --- | ---: | ---: | ---: | ---: | ---: | | Revenue | $m | not reported | not reported | not reported | [1.0](/filings/0001213900-26-036609.md) | [0.4](/filings/0001213900-26-036609.md) | | Gross margin | % | not reported | not reported | not reported | not reported | not reported | | Operating margin | % | not reported | not reported | not reported | [(2391.1%)](/filings/0001213900-26-036609.md) | [(3580.4%)](/filings/0001213900-26-036609.md) | | Net margin | % | not reported | not reported | not reported | [(2342.3%)](/filings/0001213900-26-036609.md) | [(4222.9%)](/filings/0001213900-26-036609.md) | | Diluted EPS | $ per share | [(0.92)](/filings/0001213900-23-024616.md) | [(0.92)](/filings/0001213900-24-033365.md) | [(9.51)](/filings/0001213900-25-030345.md) | [(39.39)](/filings/0001213900-26-036609.md) | [(21.79)](/filings/0001213900-26-036609.md) | | Free cash flow | $m | [(16.7)](/filings/0001213900-23-024616.md) | [(25.0)](/filings/0001213900-24-033365.md) | [(26.2)](/filings/0001213900-25-030345.md) | [(22.5)](/filings/0001213900-26-036609.md) | not reported | - Revenue. XBRL Revenue: us-gaap:Revenues. - Gross margin (gross profit / revenue). XBRL Revenue: us-gaap:Revenues. - Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:Revenues. - Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:Revenues. - Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted. - Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing. ## Insider purchases and sales The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/move/insiders.md) None in coverage. ## Funds that report holding it From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md) | Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before | | --- | --- | ---: | ---: | --- | --- | | [Dorsey & Whitney Trust CO LLC](/funds/1384042.md) | 2026-06-30 | $1.1m | 50,969 | | Added +13,436 | | [RAYMOND JAMES FINANCIAL INC](/funds/720005.md) | 2026-06-30 | $997.9k | 45,977 | | Added +13,134 | | [JANE STREET GROUP, LLC](/funds/1595888.md) | 2026-06-30 | $692.3k | 31,897 | | New +31,897 | | [NORTHERN TRUST CORP](/funds/73124.md) | 2026-06-30 | $570.0k | 26,261 | | New +26,261 | | [VANGUARD CAPITAL MANAGEMENT LLC](/funds/2100119.md) | 2026-06-30 | $468.3k | 21,576 | | Added +15,425 | | [GEODE CAPITAL MANAGEMENT, LLC](/funds/1214717.md) | 2026-06-30 | $412.1k | 18,987 | | New +18,987 | | [RENAISSANCE TECHNOLOGIES LLC](/funds/1037389.md) | 2026-06-30 | $339.6k | 15,647 | | New +15,647 | | [VANGUARD FIDUCIARY TRUST CO](/funds/933478.md) | 2026-06-30 | $182.1k | 8,392 | | Added +2,212 | | [BlackRock, Inc.](/funds/2012383.md) | 2026-06-30 | $129.8k | 5,981 | | Added +5,946 | | [MORGAN STANLEY](/funds/895421.md) | 2026-06-30 | $121.1k | 5,581 | | New +5,581 | ## Recent filings [All 326 filings](/companies/move/filings.md) | Filed | Accepted | Form | What it is | Accession | | --- | --- | --- | --- | --- | | 2026-10-14 | 20:32 ET | [8-K](/filings/0001213900-26-109462.md) | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001213900-26-109462 | | 2026-09-04 | 20:30 ET | [8-K](/filings/0001213900-26-097690.md) | 2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-26-097690 | | 2026-09-02 | 21:00 ET | [8-K](/filings/0001213900-26-096776.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001213900-26-096776 | | 2026-08-14 | 20:20 ET | [8-K](/filings/0001213900-26-090115.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001213900-26-090115 | | 2026-08-14 | 20:16 ET | [10-Q](/filings/0001213900-26-090091.md) | Quarterly report, period 2026-06-30 | 0001213900-26-090091 | | 2026-07-10 | 21:10 ET | [S-1](/filings/0001213900-26-077253.md) | Registration statement | 0001213900-26-077253 | | 2026-07-08 | 00:13 ET | [SCHEDULE 13D](/filings/0001213900-26-076497.md) | Ownership report, active investor | 0001213900-26-076497 | | 2026-07-08 | 00:13 ET | [SCHEDULE 13D](/filings/0001213900-26-076496.md) | Ownership report, active investor | 0001213900-26-076496 | | 2026-07-07 | 21:10 ET | [8-K](/filings/0001213900-26-076046.md) | 3.02 Unregistered sale of equity; 5.02 Departure or appointment of officers or directors; 5.03 Amendment to articles or bylaws; 5.07 Shareholder vote results; 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-26-076046 | | 2026-06-26 | 14:26 ET | [8-K](/filings/0001213900-26-072420.md) | 8.01 Other events | 0001213900-26-072420 | ## Latest annual report [Form 10-K for the fiscal year ended Dec 31, 2025](/filings/0001213900-26-036609.md), filed Mar 31, 2026. ## Forecast league Q3 FY2026, the quarter ended 2026-09-30, is open for forecasts until the first results filing for it is accepted by EDGAR. Results are due by \[object Promise\]. [Forecast this quarter](/leagues/2026q3/targets/6dcb0a24-3f94-4013-b045-b8bbbafec424) ## About the filer - CIK: 1734750 - Tickers: MOVE - Exchange: Nasdaq - SIC code: 7374 Services-Computer Processing & Data Preparation - State of incorporation: DE - Filer category:
Emerging growth company Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 24, 2026, 15:47 ET. No prices; not investment advice.